In the week of June 22, 2026, 21 holders filed a new Schedule 13D and 69 a new Schedule 13G reporting 5% or more of a company. The largest stake reported that week is Ilyas Khan's 72% of Quantinuum Inc (Schedule 13G, June 22, 2026).
New 13D21
New 13G69
Stated intents0
The week of 2026-06-22, 21 holders filed a new Schedule 13D and 69 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-06-24 | Made in USA Inc. | Tax Credits International Inc | 46.9% | SCHEDULE 13D |
| 2026-06-22 | XCF Global, Inc. | EEME Energy SPV I, LLC | 36.2% | SCHEDULE 13D |
| 2026-06-26 | RTB Digital, Inc. | Comer James Lamar Walton | 31.7% | SCHEDULE 13D |
| 2026-06-26 | New England Realty Associates Limited Partnership | Brown Jameson Pruitt | 31.5% | SCHEDULE 13D |
| 2026-06-24 | Lotus Technology Inc. | Etika Automotive Sdn Bhd | 27.8% | SCHEDULE 13D |
| 2026-06-25 | Office Properties Income Tru | Helix Partners Management LP | 25.3% | SCHEDULE 13D |
| 2026-06-25 | Office Properties Income Tru | Redwood Capital Management, LLC | 19.7% | SCHEDULE 13D |
| 2026-06-23 | EquipmentShare.com Inc | Jabbok Schlacks | 14.9% | SCHEDULE 13D |
| 2026-06-22 | Aditxt, Inc. | Takeover Time 2026 LLC | 10.9% | SCHEDULE 13D |
| 2026-06-26 | Cartesian Growth Corp III | WAVE Factorial Energy I, LLC | 10.7% | SCHEDULE 13D |
| 2026-06-24 | Azitra, Inc. | Salva Francisco D. | 9.99% | SCHEDULE 13D |
| 2026-06-25 | Allot Ltd. | Philotimo Fund, LP | 9.8% | SCHEDULE 13D |
| 2026-06-23 | Arax Holdings Corp. | Victor Vega | 9.7% | SCHEDULE 13D |
| 2026-06-25 | Kardigan, Inc. | Perceptive Advisors LLC | 8.9% | SCHEDULE 13D |
| 2026-06-23 | FS KKR Capital Corp. | KKR Alternative Assets L.P. | 7.8% | SCHEDULE 13D |
| 2026-06-22 | SEACOR Marine Holdings Inc. | Chernett Jorey | 7.19% | SCHEDULE 13D |
| 2026-06-22 | Health Catalyst, Inc. | Palogic Value Management, LP | 6.7% | SCHEDULE 13D |
| 2026-06-24 | Centessa Pharmaceuticals plc | Farallon Capital Management, L.L.C. | 6.1% | SCHEDULE 13D |
| 2026-06-23 | Equus Total Return, Inc. | Howard Todd Horberg | 5.61% | SCHEDULE 13D |
| 2026-06-24 | Aligos Therapeutics, Inc. | Lawrence M. Blatt | 5.6% | SCHEDULE 13D |
| 2026-06-23 | La Rosa Holdings Corp. | Benaim Eric | 5% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-06-22 | Quantinuum Inc | Ilyas Khan | 72% | SCHEDULE 13G |
| 2026-06-22 | Earth Science Tech, Inc. | Giorgio R. Saumat | 42.94% | SCHEDULE 13G |
| 2026-06-25 | Mountain Crest Acquisition 6 | Mountain Crest Holdings 6 LLC | 29.98% | SCHEDULE 13G |
| 2026-06-23 | Lakewood-Amedex Biotherapeutics Inc. | HPW Investments Holding Ltd. | 24.04% | SCHEDULE 13G |
| 2026-06-23 | WeShop Holdings Ltd | John B. Garner | 21.48% | SCHEDULE 13G |
| 2026-06-26 | Aditxt, Inc. | Wojcik Jerzy Stanislaw | 19.6% | SCHEDULE 13G |
| 2026-06-22 | FG Merger II Corp. | Atsion Asset Management LLC | 14.9% | SCHEDULE 13G |
| 2026-06-22 | Nyxoah SA | Orin Hirschman | 14.5% | SCHEDULE 13G |
| 2026-06-22 | Mammoth Energy Services, Inc. | Charles E. Davidson | 13.43% | SCHEDULE 13G |
| 2026-06-23 | Aditxt, Inc. | Tai Wey Ann | 12.3% | SCHEDULE 13G |
| 2026-06-22 | Aptevo Therapeutics Inc. | Niowave, Inc. | 12.2% | SCHEDULE 13G |
| 2026-06-23 | WeShop Holdings Ltd | Paul Teasdale | 11.86% | SCHEDULE 13G |
| 2026-06-26 | Quantum eMotion Corp. | Capital Ventures International | 11% | SCHEDULE 13G |
| 2026-06-26 | Teamshares Inc | VK Services, LLC | 10.4% | SCHEDULE 13G |
| 2026-06-23 | Tianci International, Inc. | L1 Capital Global Opportunities Master Fund, Ltd. | 9.99% | SCHEDULE 13G |
| 2026-06-23 | Faeth Therapeutics, Inc. | S2G Investments, LLC | 9.99% | SCHEDULE 13G |
| 2026-06-24 | Tianci International, Inc. | S.H.N. Financial Investments Ltd. | 9.99% | SCHEDULE 13G |
| 2026-06-24 | Azora Therapeutics, Inc. | Coastlands Capital LP | 9.98% | SCHEDULE 13G |
| 2026-06-22 | Azitra, Inc. | Stonepine Capital Management, LLC | 9.9% | SCHEDULE 13G |
| 2026-06-22 | Aditxt, Inc. | Hester Jonathan Edward | 9.9% | SCHEDULE 13G |
| 2026-06-23 | Data I/O Corp | Lytton Laurence W | 9.9% | SCHEDULE 13G |
| 2026-06-22 | DevvStream Legacy Corp. | Helena Global Investment Opportunities 1 Ltd. | 9.82% | SCHEDULE 13G |
| 2026-06-25 | Azitra, Inc. | Dauntless Investment Group, LLC | 9.6% | SCHEDULE 13G |
| 2026-06-25 | Fulcrum Therapeutics, Inc. | EcoR1 Capital, LLC | 9% | SCHEDULE 13G |
| 2026-06-25 | Fulcrum Therapeutics, Inc. | EcoR1 Capital, LLC | 9% | SCHEDULE 13G |
| 2026-06-26 | Maxeon Solar Technologies, Ltd. | Whitebox Advisors LLC | 8.5% | SCHEDULE 13G |
| 2026-06-26 | Teamshares Inc | QED Growth Fund, L.P. | 8.3% | SCHEDULE 13G |
| 2026-06-24 | HeartSciences Inc. | Fields Ephraim G | 8.1% | SCHEDULE 13G |
| 2026-06-23 | Faeth Therapeutics, Inc. | Suvretta Capital Management, LLC | 7.8% | SCHEDULE 13G |
| 2026-06-23 | WeShop Holdings Ltd | John Robert Foley | 7.62% | SCHEDULE 13G |
| 2026-06-23 | Sleep Number Corp | AQR Capital Management, LLC | 7.61% | SCHEDULE 13G |
| 2026-06-26 | Zepp Health Corp | Morgan Stanley | 7.5% | SCHEDULE 13G |
| 2026-06-26 | Volato Group, Inc. | Catheter Precision, Inc. | 7.5% | SCHEDULE 13G |
| 2026-06-25 | Passage BIO, Inc. | Baselake Partners, LP | 7.3% | SCHEDULE 13G |
| 2026-06-22 | Poet Technologies Inc. | Jane Street Group, LLC | 6.8% | SCHEDULE 13G |
| 2026-06-25 | Ryde Group Ltd | GreenTech Investment Alliance Ltd. | 6.62% | SCHEDULE 13G |
| 2026-06-23 | Yorkville International Capital Corp. | Tenor Capital Management Company, L.P. | 6.5% | SCHEDULE 13G |
| 2026-06-26 | Wilco 63 Corp. | MMCAP International Inc. SPC | 6.5% | SCHEDULE 13G |
| 2026-06-23 | Insight Enterprises Inc | Fiduciary Management Inc | 6.2% | SCHEDULE 13G |
| 2026-06-24 | Cantor Equity Partners VII, Inc. | RP Investment Advisors LP | 6.2% | SCHEDULE 13G |
| 2026-06-25 | SRX Global Inc. | Les Filles, LLC | 6.2% | SCHEDULE 13G |
| 2026-06-23 | Sleep Number Corp | Jane Street Group, LLC | 6.1% | SCHEDULE 13G |
| 2026-06-24 | HCM III Acquisition Corp | RP Investment Advisors LP | 6.1% | SCHEDULE 13G |
| 2026-06-25 | AstroNova Inc | Glazer Capital, LLC | 5.81% | SCHEDULE 13G |
| 2026-06-23 | Omada Health Inc | The Cigna Group | 5.8% | SCHEDULE 13G |
| 2026-06-23 | Pasithea Therapeutics Corp. | Stonepine Capital Management, LLC | 5.8% | SCHEDULE 13G |
| 2026-06-24 | DXC Technology Co | Millennium Management LLC | 5.7% | SCHEDULE 13G |
| 2026-06-25 | Soligenix, Inc. | Michael Liu | 5.7% | SCHEDULE 13G |
| 2026-06-23 | Huron Consulting Group Inc. | Fiduciary Management Inc | 5.5% | SCHEDULE 13G |
| 2026-06-23 | Lakefront Biotherapeutics NV | Madison Avenue International LP | 5.5% | SCHEDULE 13G |
| 2026-06-23 | Aditxt, Inc. | Burciu Emil Cristian | 5.5% | SCHEDULE 13G |
| 2026-06-26 | CervoMed Inc. | CVI Investments, Inc. | 5.5% | SCHEDULE 13G |
| 2026-06-22 | Cantor Equity Partners VII, Inc. | MMCAP International Inc. SPC | 5.3% | SCHEDULE 13G |
| 2026-06-24 | Ascent Solar Technologies, Inc. | Jane Street Group, LLC | 5.3% | SCHEDULE 13G |
| 2026-06-23 | Jiuzi Holdings, Inc. | Jane Street Group, LLC | 5.2% | SCHEDULE 13G |
| 2026-06-24 | Mbx Biosciences Inc | Paradigm BioCapital Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-06-25 | AIB Data Centers Inc. | Point72 Asset Management, L.P. | 5.2% | SCHEDULE 13G |
| 2026-06-25 | Unifi, Inc. | Peter J Abrahamson | 5.2% | SCHEDULE 13G |
| 2026-06-25 | Wilco 63 Corp. | Sculptor Capital LP | 5.19% | SCHEDULE 13G |
| 2026-06-22 | GPGI, Inc. | Locust Wood Capital Advisers, LLC | 5.1% | SCHEDULE 13G |
| 2026-06-22 | Cracker Barrel Old Country Store, Inc. | D. E. Shaw & Co., L.P. | 5.1% | SCHEDULE 13G |
| 2026-06-24 | Galaxy Digital Inc. | Jane Street Group, LLC | 5.1% | SCHEDULE 13G |
| 2026-06-25 | Leslie's, Inc. | Jane Street Group, LLC | 5.1% | SCHEDULE 13G |
| 2026-06-26 | Viridian Therapeutics, Inc. | Paradigm BioCapital Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-06-26 | Lenz Therapeutics Inc | Millennium Management LLC | 5.1% | SCHEDULE 13G |
| 2026-06-26 | Teamshares Inc | Spark Growth Management Partners III, LLC | 5.1% | SCHEDULE 13G |
| 2026-06-26 | Drugs Made In America Acquisition Corp. | Feis Equities LLC | 5.08% | SCHEDULE 13G |
| 2026-06-23 | Talen Energy Corp | ECP ControlCo, LLC | 5.01% | SCHEDULE 13G |
| 2026-06-22 | Teladoc Health Inc | Voss Capital, LP | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Download this data (CSV)90 rows, with sources. Free with an account.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.